DARZALEX (daratumumab) Patient Assistance Program
Don’t let the high cost of brand specialty multiple myeloma therapy stand between you and the treatment you need. We help eligible patients access Darzalex (daratumumab) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Darzalex (daratumumab) is FDA-approved across multiple multiple myeloma indications — newly diagnosed and relapsed/refractory disease — used in combination with lenalidomide/dexamethasone, bortezomib/melphalan/prednisone, bortezomib/thalidomide/dexamethasone, pomalidomide/dexamethasone, and other regimens. A subcutaneous formulation (Darzalex Faspro) is also available.
- Without assistance, brand Darzalex IV costs commonly run $5,000–$8,000+ per infusion; Darzalex Faspro SC commonly runs $5,500–$7,500 per dose. Annual treatment costs commonly reach $130,000+.
- Through AffordMyPrescriptions, qualifying patients can access Darzalex (or Faspro SC) for a flat $69.95 per month — our advocacy team manages the entire enrollment, infusions, and renewal process.
- There is no biosimilar version of Darzalex available in the U.S. as of 2026.
What Is Darzalex Prescription Assistance Program?
The Darzalex Prescription Assistance Program is a manufacturer-sponsored initiative that provides Darzalex at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for multiple myeloma patients who are uninsured or underinsured, as well as Medicare beneficiaries.
Navigating the program on your own means dealing with eligibility verification, oncology-team coordination, prior-authorization documentation, infusion scheduling (or SC injection coordination for Faspro), HBV screening, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing infusion-schedule coordination and annual re-certification — so you focus on your treatment, not paperwork.
Pharmacy Price Comparison
- Without assistance, Darzalex costs roughly $5,000–$8,000+ per infusion. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Darzalex IV per dose | ~$7,000.00 | Save ~$6,930/dose |
| Darzalex Faspro SC per dose | ~$6,500.00 | Save ~$6,430/dose |
| Weekly induction | ~$28,000+/mo | Save ~$27,930/mo |
| Monthly maintenance | ~$7,000+ | Save ~$6,930/mo |
| Annual cost (typical) | ~$130,000+ | Save ~$129,000+/yr |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Darzalex Prescription Program?
The Patient Assistance Program is free to apply for and provides Darzalex at no medication cost if approved. But the process involves detailed applications, oncology-team coordination, prior-authorization documentation, infusion or SC injection scheduling, HBV screening, and ongoing renewal management. Our $69.95/month service covers full advocacy.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Darzalex:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
- Still $5,000–$8,000+ per dose per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Darzalex assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Darzalex Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured Or Underinsured And Cannot Afford Your Medication
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Darzalex:
Darzalex (daratumumab) is an anti-CD38 monoclonal antibody used to treat multiple myeloma. It is given as an IV infusion (Darzalex) or as a subcutaneous injection (Darzalex Faspro, with hyaluronidase) — the SC form takes only 3–5 minutes vs. several hours for IV. Darzalex is approved across newly diagnosed and relapsed/refractory disease in multiple combination regimens.
How Darzalex Works:
Multiple myeloma targets plasma cells in the bone marrow that express a specific protein called CD38. Darzalex is a monoclonal antibody that binds to this protein, triggering the immune system to destroy malignant cells through several pathways, including direct cell death and immunomodulatory effects. This multi-pronged approach makes it a foundational therapy for achieving deep responses across various treatment lines.
Form and use:
Darzalex is available as an intravenous infusion (Darzalex IV) or a quicker subcutaneous injection (Darzalex Faspro SC). The typical schedule starts with weekly doses for the first two months, gradually decreasing to every four weeks for maintenance. To minimize the risk of reactions, patients receive premedications such as corticosteroids, acetaminophen, and antihistamines before each administration.
Generic availability:
As of 2026, there is no FDA-approved biosimilar version of Darzalex available in the United States. While other anti-CD38 antibodies like Sarclisa are approved for certain uses, Darzalex remains a unique branded option. Other myeloma treatments, including generic immunomodulatory drugs like lenalidomide and newer BCMA-directed therapies, provide alternative paths for patient care.
Warnings:
Serious infusion reactions are a primary concern, particularly during the first dose, necessitating mandatory premedication. Patients must undergo screening for Hepatitis B due to the risk of viral reactivation and should be aware that the drug can interfere with blood-typing and lab crossmatching. It is vital to report symptoms like fever, jaundice, or persistent fatigue to your oncology team immediately.
FAQ (Frequently Asked Questions)
How Much Does Darzalex Cost Without Insurance?
Per-dose costs commonly run $5,000–$8,000+ for Darzalex IV; Darzalex Faspro SC is similar. Annual treatment costs commonly reach $130,000+. Through AffordMyPrescriptions, qualifying patients receive Darzalex at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
What Is The Difference Between Darzalex IV And Darzalex Faspro SC?
Both contain the same active ingredient (daratumumab). Darzalex IV is given as a 3–7-hour IV infusion. Darzalex Faspro SC is combined with hyaluronidase enzyme to enable subcutaneous administration over 3–5 minutes — a major time savings. Both are clinically equivalent. Most patients prefer the SC form for convenience.
Why Is HBV Screening Required?
Darzalex (and other anti-CD38 antibodies) carry a risk of reactivating chronic or resolved hepatitis B virus (HBV) infection. Before starting therapy, you’ll be screened for HBV (HBsAg and anti-HBc), and if you have evidence of prior infection, you’ll typically be co-treated with an antiviral throughout therapy and for several months after.Open the cover until you hear a click. Breathe out fully (away from the inhaler). Place the mouthpiece in your mouth, close your lips around it, and inhale long and steadily. Hold your breath for 3–4 seconds. Close the cover. Rinse your mouth with water. The Ellipta tracks each dose automatically — the dose counter shows how many doses are left.
Why Does Darzalex Interfere With Blood Tests?
Darzalex binds to CD38 on red blood cells, which can interfere with blood-bank crossmatching tests and produce a false-positive indirect antiglobulin test. Your oncology team will alert your blood bank that you are on Darzalex so they can use special techniques (DTT-treated cells) for crossmatching if you need a transfusion.Darzalex binds to CD38 on red blood cells, which can interfere with blood-bank crossmatching tests and produce a false-positive indirect antiglobulin test. Your oncology team will alert your blood bank that you are on Darzalex so they can use special techniques (DTT-treated cells) for crossmatching if you need a transfusion.
Are There Other Myeloma Therapies I Should Know About?
Yes. Other options include isatuximab (Sarclisa, also anti-CD38), proteasome inhibitors (bortezomib, carfilzomib, ixazomib), immunomodulatory drugs (lenalidomide and pomalidomide are now generic), BCMA-directed therapies (Tecvayli, Talvey, Carvykti, Abecma), and CAR-T cell therapy. Whether any is a better clinical fit depends on prior treatments and tolerability.
Can I Get Darzalex Through The PAP If I Have Medicare?
Yes. Medicare beneficiaries can typically qualify for Darzalex Patient Assistance, especially if you face significant out-of-pocket costs under medical or pharmacy benefits. The manufacturer’s commercial copay assistance program is reserved for commercially insured patients only.
What If My Application Is Denied?
If your initial application is denied, we explore alternatives — the manufacturer’s copay assistance program if you have commercial insurance, independent foundations such as the PAN Foundation, HealthWell Foundation, International Myeloma Foundation, Multiple Myeloma Research Foundation, or Leukemia & Lymphoma Society, or asking your oncology team whether a different myeloma combination would be appropriate. If we cannot find a path, you will not be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Darzalex, our team may be able to help you access assistance programs designed to make brand specialty multiple myeloma therapy affordable. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.